ACELYRIN, INC. vs Aiolos Bio
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new treatment options for patients
103 employees · est. 2020 · Agoura Hills, United States
ACELYRIN, INC. is the older company (2020 vs 2023); ACELYRIN, INC. is the larger of the two.
Side-by-Side Comparison
| Metric | ACELYRIN, INC. | Aiolos Bio |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2023 |
| Headquarters | ||
| Headquarters | Agoura Hills, United States | San Francisco, United States |
| Employees | ||
| Employees | 103 larger | 3 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Acquired | Series A |
| Total Funding | ||
| Total Funding | $1.10B | $245.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 1 |
| Services | ||
| Services | therapy development, research and development, clinical trial management, data analytics for drug development, patient resource provision | Medicine Development, Vaccine Delivery, Scientific Research, Health Security Solutions |
| Target Customers | ||
| Target Customers | patients with immune-mediated diseases, healthcare providers, pharmaceutical investors, medical researchers, biotech stakeholders | Patients, Healthcare Professionals, Investors, Global Health Organizations |
| Taxonomy | ||
| Taxonomy | Late-stage Clinical BiopharmaPatient-focusedLife-changing Treatment OptionsDrug AcquisitionDevelopment AccelerationCommercialization +6 | BiopharmaRespiratory DiseaseImmunological DisordersDrug DevelopmentClinical StageSan Francisco Bay Area +8 |
| Website | ||
| Website | acelyrin.com | aiolosbio.com |
About ACELYRIN, INC.
ACELYRIN, INC. is a biopharmaceutical company headquartered in the United States with operations in the Los Angeles and San Francisco Bay areas. Founded in 2020, the company is strategically positioned in the Biopharma, Biotechnology, and Health Care industries, focusing on late-stage clinical devel...
About Aiolos Bio
Aiolos Bio, founded in 2023, is a promising biopharmaceutical startup revolutionizing treatment approaches for respiratory diseases and immunological disorders. Based in the San Francisco Bay Area with additional operations in London, UK, the company is focused on developing an innovative anti-TSLP...
Also comparing in this category
Comparing more than these two?
Get ACELYRIN, INC., Aiolos Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does ACELYRIN, INC. compare?
A PDF of ACELYRIN, INC. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare ACELYRIN, INC. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ACELYRIN, INC. on 28 Jan 2026, and Aiolos Bio on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
